ABPI response to Safer Working Guidance
Following the announcement to ease lockdown measures in England, the UK government has published guidance to support the safe return to work for people in various sectors.
Many pharmaceutical companies have been working around the clock throughout the pandemic to research new vaccines and treatments for COVID-19 and to supply medicines to people who need them. Richard Torbett
This guidance is welcome in providing more detail on the Government’s plans to make sure there are safe return to work guidelines in place for everyone working in life sciences. Richard Torbett
The ABPI and member companies contributed to some of the guidelines most relevant to life sciences.
In response to the announcement, ABPI Chief Executive Richard Torbett said:
"Pharmaceutical companies have been working around the clock throughout the pandemic to research new vaccines and treatments for COVID-19 and to supply medicines to people who need them.
"This guidance is welcome in providing more detail on the Government’s plans to make sure there are safe return to work guidelines in place for everyone working in life sciences.
"We will continue to work closely with our members and partners from all parts of the UK as further guidance develops to ensure it can support a practical and safe return to work for all staff."
Last modified: 20 September 2023
Last reviewed: 20 September 2023